Combination & Conjugate Vaccines


Increasingly, more diseases are becoming vaccine preventable, but maintaining community and provider acceptance demands that the number of injections doesn’t increase. Combination conjugate vaccines represent an inevitable and important advance. This paper reviews the efficacy and safety of combination conjugate vaccines, including immunological mechanisms underlying interactions among vaccine epitopes, the role of immunological memory, and correlates of immunity. Specific attention is given to the experience with combination vaccines against each of Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis. The implications of these findings for different communities are discussed, key areas for further research identified and implications for post-licensure monitoring addressed.


  • BCG vaccines
  • Dtap, Tdap vaccines
  • MMR (Measles, Mumps, and Rubella) vaccines
  • Mumps and rubella (Mu-Rub) vaccines
  • Diphtheria and tetanus toxoids (DT) vaccines
  • Formulation technologies used for conjugated vaccines
  • Peptides, Carbohydrates and Antigens containing vaccines

Related Conference of Combination & Conjugate Vaccines

May 30-31, 2024

World congress on Immunology and Virology Diseases

Vienna, Austria
August 01-02, 2024

44th Global Summit and Expo on Vaccines & Immunology

Montreal, Canada
September 09-10, 2024

4th International Conference on Vaccine Research

Madrid, Spain
November 28-29, 2024

6th World Congress on Vaccine and Immunology

Paris, France

Combination & Conjugate Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in